W
Won Ki Kang
Researcher at Samsung Medical Center
Publications - 385
Citations - 18420
Won Ki Kang is an academic researcher from Samsung Medical Center. The author has contributed to research in topics: Cancer & Capecitabine. The author has an hindex of 59, co-authored 368 publications receiving 14746 citations. Previous affiliations of Won Ki Kang include Sungkyunkwan University & Samsung.
Papers
More filters
Journal ArticleDOI
Epigenomic promoter alterations predict for benefit from immune checkpoint inhibition in metastatic gastric cancer.
Raghav Sundar,Raghav Sundar,Kie Kyon Huang,Aditi Qamra,Kyoung-Mee Kim,Seungtae Kim,Won Ki Kang,Angie Lay-Keng Tan,J.W. Lee,Patrick Tan +9 more
TL;DR: A substantial proportion of metastatic gastric cancers utilize alternate promoters as a mechanism of immune evasion, and these tumors may be resistant to anti-PD1 immune checkpoint inhibition, and a novel predictive biomarker for immunotherapy.
Journal ArticleDOI
Tuberculosis in hematopoietic stem cell transplant recipients in Korea.
Jeeyun Lee,Mark Hong Lee,Won Seog Kim,Kihyun Kim,Se Hoon Park,Se-Hoon Lee,Kyung-Bun Lee,Jinny Park,Joon Oh Park,Chul Won Jung,Young-Hyuck Im,Won Ki Kang,Keunchil Park +12 more
TL;DR: Analysis at the univariate level indicated that a conditioning regimen with total body irradiation (TBI), chronic graft-versus-host disease, and a previous history of TB infection were significant risk factors for the development ofTB infection after HSCT, and isoniazid prophylaxis may benefit HSCT recipients with a previousHistory of active TB infection.
Journal ArticleDOI
Anemia is the strongest prognostic factor for outcomes of 5-fluorouracil-based first-line chemotherapy in patients with advanced gastric cancer
Se Hoon Park,Jeeyun Lee,Se-Hoon Lee,Joon Oh Park,Kihyun Kim,Won Seog Kim,Chul Won Jung,Young Suk Park,Won Ki Kang,Keunchil Park,Seonwoo Kim,Soo Mee Bang,Eun Kyung Cho,Dong Bok Shin,Jae Hoon Lee +14 more
TL;DR: Low baseline Hgb level is a strong and independent prognostic factor for the outcomes of AGC patients receiving FU-based first-line chemotherapy and may be considered as a stratification variable in subsequent studies ofAGC.
Journal ArticleDOI
Pulmonary complications after hematopoietic stem cell transplantation.
Do Hyoung Lim,Jeeyun Lee,Hong Ghi Lee,Byeong Bae Park,Kyong Ran Peck,Won Sup Oh,Sang Hoon Ji,Se-Hoon Lee,Joon Oh Park,Kihyun Kim,Won Seog Kim,Chul Won Jung,Young Suk Park,Young-Hyuck Im,Won Ki Kang,Keunchil Park +15 more
TL;DR: Allogeneic transplant, grade II-IV acute graft-versus-host disease (GVHD) and extensive chronic GVHD were the risk factors with statistical significance for pulmonary complications after hematopoietic stem cell transplantation (HSCT).
Journal ArticleDOI
Rapamycin-insensitive companion of mTOR (RICTOR) amplification defines a subset of advanced gastric cancer and is sensitive to AZD2014-mediated mTORC1/2 inhibition.
Seungtae Kim,Sun Young Kim,Samuel J. Klempner,J. Yoon,Nayoung K.D. Kim,Soomin Ahn,Heejin Bang,Kyoung-Mee Kim,Woong-Yang Park,Silvia Park,J. O. Park,Y.S. Park,Ho Yeong Lim,Se-Hoon Lee,Kwan Park,Won Ki Kang,Jeeyun Lee +16 more
TL;DR: The results support further pre-clinical and clinical investigation with AZD2014 in RICTOR amplified gastric cancer and highlights the importance of genomic profiling.